QS Investors LLC Lowers Position in HCA Healthcare Inc (HCA)
QS Investors LLC trimmed its holdings in shares of HCA Healthcare Inc (NYSE:HCA) by 13.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 13,633 shares of the company’s stock after selling 2,086 shares during the quarter. QS Investors LLC’s holdings in HCA Healthcare were worth $1,198,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Parallel Advisors LLC increased its stake in HCA Healthcare by 76.2% during the 4th quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock worth $117,000 after purchasing an additional 578 shares in the last quarter. Bronfman E.L. Rothschild L.P. increased its stake in HCA Healthcare by 108.0% during the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock worth $213,000 after purchasing an additional 1,259 shares in the last quarter. Kovack Advisors Inc. bought a new stake in HCA Healthcare during the 4th quarter worth approximately $234,000. Financial Counselors Inc. bought a new stake in HCA Healthcare during the 4th quarter worth approximately $243,000. Finally, Focused Wealth Management Inc bought a new stake in HCA Healthcare during the 4th quarter worth approximately $257,000. 73.45% of the stock is owned by institutional investors and hedge funds.
A number of research firms recently issued reports on HCA. Mizuho began coverage on HCA Healthcare in a research note on Friday. They set a “buy” rating and a $115.00 target price for the company. Zacks Investment Research cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Tuesday. Argus increased their target price on HCA Healthcare from $9.26 to $114.00 and gave the stock a “buy” rating in a research note on Monday, February 12th. Sanford C. Bernstein reissued a “market perform” rating and set a $116.00 target price (up from $105.00) on shares of HCA Healthcare in a research note on Thursday, February 1st. Finally, BMO Capital Markets increased their target price on HCA Healthcare from $96.00 to $115.00 and gave the stock an “outperform” rating in a research note on Thursday, February 1st. They noted that the move was a valuation call. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and seventeen have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $106.05.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 30th. The company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.87 by $0.25. The company had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. HCA Healthcare had a negative return on equity of 49.49% and a net margin of 4.89%. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.80 EPS. analysts forecast that HCA Healthcare Inc will post 8.71 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Stockholders of record on Thursday, March 1st will be issued a $0.35 dividend. This represents a $1.40 annualized dividend and a dividend yield of 1.40%. The ex-dividend date is Wednesday, February 28th. HCA Healthcare’s payout ratio is presently 23.57%.
In other news, insider Charles J. Hall sold 119,637 shares of the stock in a transaction that occurred on Wednesday, February 14th. The stock was sold at an average price of $100.14, for a total value of $11,980,449.18. Following the completion of the sale, the insider now owns 161,181 shares of the company’s stock, valued at approximately $16,140,665.34. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, SVP Joseph A. Sowell III sold 58,175 shares of the stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $95.00, for a total value of $5,526,625.00. Following the completion of the sale, the senior vice president now directly owns 40,536 shares of the company’s stock, valued at approximately $3,850,920. The disclosure for this sale can be found here. In the last three months, insiders sold 479,918 shares of company stock valued at $48,186,093. 2.90% of the stock is currently owned by insiders.
TRADEMARK VIOLATION NOTICE: “QS Investors LLC Lowers Position in HCA Healthcare Inc (HCA)” was originally published by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was stolen and reposted in violation of US and international trademark & copyright laws. The correct version of this article can be viewed at https://www.watchlistnews.com/qs-investors-llc-lowers-position-in-hca-healthcare-inc-hca/1960766.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.